Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Registry on the Use of HaemoCer-PLUSPlus in the Treatment and Prevention of Post-resectional Bleeding

NCT05443815 is registered in ClinicalTrials.gov with Istituto Clinico Humanitas Mater Domini as lead sponsor.

NCT NCT05443815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05443815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Registry on the Use of HaemoCer-PLUSPlus in the Treatment and Prevention of Post-resectional Bleeding
Lead sponsor
Istituto Clinico Humanitas Mater Domini
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2022
Completion date
July 30, 2023
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-resectional bleeding